Indian auto industry may face disruption amid China's stricter Rare Earth export controls: Report
The report mentioned that China, which accounts for over 70 per cent of global REE production and controls more than 90 per cent of refining capacity, imposed stricter export regulations on several REEs from April 2025, citing national security and non-proliferation concerns.
The report said 'The licensing for exports has become significantly longer. These delays have led to supply uncertainty across sectors reliant on these critical inputs'.
It pointed out that electric passenger vehicles (E-PVs) and internal combustion engine passenger vehicles (ICE-PVs) are the most vulnerable within the Indian auto industry.
Electric vehicles (EVs), passenger vehicles (PVs), two-wheelers (2Ws), and commercial vehicles (CVs), in that order, are likely to face the maximum disruption.
High-performance EV motors, teh report said, require heavy rare earth elements (HREEs) such as dysprosium and terbium to maintain efficiency at high operating temperatures.
For electric two-wheelers (E-2Ws), magnets used in motors cost around Rs 150, while in PVs the cost varies from Rs 2,000 to Rs 24,000 depending on the features. However, the issue is not just about cost but the availability of these critical components and the limited options for alternative sourcing.
While ICE 2Ws and 3Ws remain relatively unaffected in the short term, E-2Ws that use permanent magnet synchronous motors (PMSMs) are more vulnerable because of their limited design flexibility.
As per report, while E-2Ws may undergo design changes in a short time (2-3 months), PVs and buses may require 6-12 months for complete motor redesigns due to stricter performance and space requirements.
According to the Society of Indian Automobile Manufacturers (SIAM), ICE-PV production could face cuts starting July 2025, while existing E-2W inventories may last only another 1 to 1.5 months unless alternative sourcing arrangements are made.
Although countries like Brazil and Australia hold substantial REE reserves, with Brazil alone having 20 per cent of global reserves, China continues to exert significant financial and operational control over many of these resources.
Chinese companies also hold stakes in Brazilian mines. In addition, while Vietnam and Malaysia host some refining capacity, they largely lack access to primary raw materials and remain dependent on China.
The tightening of export controls by China is likely to create ripple effects across the global supply chain, with India's auto sector bracing for a challenging period ahead. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
3 hours ago
- The Sun
Trump proposes 250% tariff on imported pharmaceuticals
WASHINGTON: US President Donald Trump revealed plans to impose tariffs on imported pharmaceuticals that could escalate to 250%, alongside new duties on foreign semiconductors. The move aims to push for domestic manufacturing of critical goods. 'We'll be putting (an) initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150 percent,' Trump said in an interview on CNBC. 'And then it's going to go to 250 percent because we want pharmaceuticals made in our country.' The announcement follows earlier tariffs on steel, aluminum, and auto parts, part of Trump's broader trade strategy targeting imports deemed a national security concern. The administration has conducted investigations into pharmaceuticals and semiconductors, signaling upcoming policy shifts. Trump also indicated an imminent increase in tariffs on Indian imports, citing the country's purchases of Russian oil. 'I expect to raise the US tariff on Indian imports very substantially over the next 24 hours,' he said. The proposed pharmaceutical tariffs mark a significant escalation in trade measures, potentially disrupting global supply chains. Industry analysts warn of higher drug prices, while supporters argue it will strengthen US self-sufficiency. - AFPpix
The Sun
3 hours ago
- The Sun
Malaysia sets sights on becoming Asean pharmaceutical and healthcare hub
KUALA LUMPUR: Malaysia is setting its sights on becoming a halal pharmaceutical and healthcare hub for Asean, leveraging partnerships with India's booming pharma sector as industry leaders prepare for the Second Malaysia Pharma and Healthcare Expo (MPHC 2025) in October. The expo, to be held at the World Trade Centre Kuala Lumpur from Oct 7 to 9, is expected to attract over 100 companies, up from 70 last year, alongside policymakers, researchers and investors across Asean, India, Australia and South Korea. Organisers say the event will spotlight innovations in halal-certified drugs, active pharmaceutical ingredients (APIs), biotech, regenerative medicine, telehealth and AI-driven diagnostics. Malaysia-India Business Council general secretary Datuk Surendran Menon said trade between Malaysia and India stood at US$20 billion (RM84.6 billion) in 2024, but pharmaceuticals made up just US$96–$104 million of that figure, a sign of significant untapped potential. 'India is known as the pharma of the world, while Malaysia offers halal regulation expertise and a strategic Asean strong potential in contract manufacturing, technology transfer and joint R&D, especially in halal pharmaceuticals and vaccines,' Surendran told reporters at a media briefing today. He said Malaysia imports over 70% of its pharmaceutical products, and the government's national pharmaceutical policy is pushing for greater domestic production, a move that could entice Indian firms seeking to expand into Asean markets. He also pointed to India's own 200 million-strong Muslim population as an untapped market for halal pharma products manufactured in Malaysia. 'Even if we tap just 50 million of that halal market in India, it's far larger than our domestic market here. Halal-certified medicines made in Malaysia could be exported not just across Asean but also back into India itself,' he said. This strategy, he added, would allow two-way investment flows, Indian companies bringing R&D and cost efficiencies to Malaysia, while Malaysian firms could set up manufacturing or joint ventures in India. Asean-India Economic Council chairman Datuk Ramesh Kodammal said Malaysia stands to benefit from India's US$50 billion pharmaceutical export industry, particularly as Asean and India review their free trade agreement, which has been in place for 11 years. 'If we work closely with India, we will have a lot of benefit,' he said, adding Malaysia has a great advantage of re-exporting with these Indian companies for the Asean market a huge market of 700 million people. Ramesh confirmed 40 Indian companies are slated to participate in MPHC 2025, alongside Asean, Australian and South Korean firms.
The Star
4 hours ago
- The Star
Trump says he will ‘substantially' raise tariffs on India over Russian oil purchases
US President Donald Trump said he will substantially raise tariffs on India. - Photo: Reuters WASHINGTON: President Donald Trump said he would raise tariffs on Indian goods "over the next 24 hours' in response to New Delhi's continued purchases of Russian oil. Trump announced a 25% duty on India's exports to the US and has threatened repeatedly to increase that rate to punish the country for buying Russian energy, an effort to pressure Russian President Vladimir Putin to end the war in Ukraine. "We settled on 25% but I think I'm going to raise that very substantially over the next 24 hours, because they're buying Russian oil,' Trump said Tuesday (Aug 5) in a CNBC interview. "They're fueling the war machine. And if they're going to do that, then I'm not going to be happy.' Trump has escalated his fight with India over trade, unilaterally imposing a tariff rate after months of negotiations failed to secure a deal. He accused New Delhi of refusing to ease access for American goods and criticizing its membership in the BRICS group of developing economies. The US president has also set an Aug. 8 deadline for Russia to reach a truce with Ukraine, with the administration threatening so-called secondary sanctions on countries that purchase energy from Moscow. Ukraine's allies say those purchases prop up Putin's war effort. Trump in the interview said that if energy prices went down it would undercut Putin's ability to continue his invasion of Ukraine - now in its fourth year. "If energy goes down low enough, Putin's going to stop killing people,' Trump said. "If you get energy down another US$10 a barrel, he's going to have no choice, because his economy stinks.' The Indian government has indicated it intends to continue talks with the US in hopes of securing lower tariffs. It has also called Trump's threat over energy purchases unjustified. India is considering ramping up natural gas purchases from the US and increasing imports of communication equipment and gold. - Bloomberg
